S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Relay Therapeutics (RLAY) News Today

$10.08
+0.06 (+0.60%)
(As of 03/1/2024 ET)
SourceHeadline
marketbeat.com logoRelay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by Algert Global LLC
marketbeat.com - February 27 at 6:54 AM
globenewswire.com logoRelay Therapeutics to Participate in Three Upcoming Investor Conferences
globenewswire.com - February 26 at 4:05 PM
markets.businessinsider.com logoRelay Therapeutics: Strong Buy on Improved Financials and Promising Future Milestones
markets.businessinsider.com - February 26 at 2:36 PM
MarketBeat logoHead-To-Head Review: ZIVO Bioscience (NASDAQ:ZIVO) vs. Relay Therapeutics (NASDAQ:RLAY)
americanbankingnews.com - February 26 at 1:52 AM
fool.com logoRelay Therapeutics (NASDAQ: RLAY)
fool.com - February 25 at 8:02 AM
finance.yahoo.com logoRelay Therapeutics Full Year 2023 Earnings: Beats Expectations
finance.yahoo.com - February 24 at 10:09 AM
MarketBeat logoRelay Therapeutics (NASDAQ:RLAY) PT Raised to $30.00
americanbankingnews.com - February 24 at 4:08 AM
MarketBeat logoRelay Therapeutics (NASDAQ:RLAY) Sees Unusually-High Trading Volume Following Earnings Beat
americanbankingnews.com - February 24 at 2:02 AM
marketbeat.com logoRelay Therapeutics (NASDAQ:RLAY) Announces Earnings Results
marketbeat.com - February 23 at 12:53 PM
marketbeat.com logoRelay Therapeutics (NASDAQ:RLAY) Sees Large Volume Increase on Better-Than-Expected Earnings
marketbeat.com - February 23 at 11:32 AM
finanznachrichten.de logoRelay Therapeutics, Inc.: Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
finanznachrichten.de - February 23 at 7:55 AM
markets.businessinsider.com logoOptimistic Buy Rating for Relay Therapeutics: Strong Financial Standing and Strategic Pipeline Focus
markets.businessinsider.com - February 22 at 9:54 PM
finance.yahoo.com logoRelay Therapeutics Inc (RLAY) Reports Full Year 2023 Financial Results and Corporate Highlights
finance.yahoo.com - February 22 at 9:54 PM
globenewswire.com logoRelay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
globenewswire.com - February 22 at 4:05 PM
benzinga.com logoRelay Therapeutics's Earnings: A Preview
benzinga.com - February 21 at 6:00 PM
investing.com logoRelay Therapeutics Inc (RLAY)
investing.com - February 21 at 12:59 PM
marketbeat.com logoRafferty Asset Management LLC Lowers Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY)
marketbeat.com - February 21 at 6:43 AM
finance.yahoo.com logoRLAY Mar 2024 7.500 put
finance.yahoo.com - February 17 at 10:36 AM
marketbeat.com logoRelay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Lowered by Barclays PLC
marketbeat.com - February 17 at 5:26 AM
finance.yahoo.com logoVERV Mar 2024 12.500 call
finance.yahoo.com - February 16 at 11:23 PM
marketbeat.com logoRelay Therapeutics (RLAY) to Release Quarterly Earnings on Thursday
marketbeat.com - February 16 at 9:53 AM
finance.yahoo.com logoRelay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
finance.yahoo.com - February 15 at 7:53 PM
globenewswire.com logoRelay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
globenewswire.com - February 15 at 4:05 PM
markets.businessinsider.com logoRelay Therapeutics Poised for Growth with Promising RLY-2608, Analyst Maintains Buy Rating
markets.businessinsider.com - February 15 at 9:47 AM
finance.yahoo.com logoRelay Therapeutics, Inc. (RLAY) Moves 10.0% Higher: Will This Strength Last?
finance.yahoo.com - February 15 at 9:47 AM
marketbeat.com logoRelay Therapeutics, Inc. (NASDAQ:RLAY) Expected to Earn FY2027 Earnings of ($2.34) Per Share
marketbeat.com - February 15 at 8:59 AM
seekingalpha.com logoRelay Therapeutics: Tapping Into An Unmet Need At A High Price Tag
seekingalpha.com - February 12 at 9:41 PM
finance.yahoo.com logoRelay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
finance.yahoo.com - February 1 at 8:20 PM
marketbeat.com logoRelay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of "Moderate Buy" from Analysts
marketbeat.com - January 27 at 2:53 AM
marketbeat.com logoTD Asset Management Inc Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)
marketbeat.com - January 18 at 5:31 AM
msn.com logoRelay Therapeutics to sell 2.5M shares at $12.00 in private placement
msn.com - January 10 at 9:14 AM
benzinga.com logoRelay Therapeutics Stock (NASDAQ:RLAY), Short Interest Report
benzinga.com - January 9 at 7:59 AM
finance.yahoo.com logoRelay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 5:27 PM
marketbeat.com logoRelay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - January 2 at 2:37 AM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for Relay Therapeutics: Here's What You Need To Know
markets.businessinsider.com - December 11 at 12:41 PM
marketbeat.com logoRelay Therapeutics (NASDAQ:RLAY) PT Lowered to $17.00
marketbeat.com - December 11 at 8:16 AM
finance.yahoo.com logoWall Street Analysts Think Relay Therapeutics, Inc. (RLAY) Could Surge 189.21%: Read This Before Placing a Bet
finance.yahoo.com - November 30 at 2:54 PM
marketbeat.com logoUnlocking AI investment opportunities in healthcare (RLAY)
marketbeat.com - November 16 at 9:00 AM
finance.yahoo.com logoWall Street Analysts See a 202.33% Upside in Relay Therapeutics, Inc. (RLAY): Can the Stock Really Move This High?
finance.yahoo.com - November 14 at 1:46 PM
benzinga.com logoRelay Therapeutics Stock (NASDAQ:RLAY), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 9 at 9:38 AM
finance.yahoo.com logoRelay Therapeutics to Participate in Stifel 2023 Healthcare Conference
finance.yahoo.com - November 7 at 7:48 PM
markets.businessinsider.com logoRelay Therapeutics’ Promising Clinical Outlook and Solid Financial Position Earns Buy Rating
markets.businessinsider.com - November 6 at 5:42 PM
seekingalpha.com logoRelay Therapeutics: Market Is Underestimating Lirafugratinib's Potential (Rating Upgrade)
seekingalpha.com - November 6 at 2:05 AM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), AnaptysBio (ANAB)
markets.businessinsider.com - November 3 at 9:37 AM
finance.yahoo.com logoRelay Therapeutics Inc (RLAY) Reports Q3 2023 Financial Results: Revenue Surges to $25.2 Million
finance.yahoo.com - November 2 at 10:42 PM
finance.yahoo.com logoRelay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
finance.yahoo.com - November 2 at 5:41 PM
finance.yahoo.com logoRelay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023
finance.yahoo.com - October 26 at 6:22 PM
finance.yahoo.com logoRelay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - October 26 at 1:22 PM
finance.yahoo.com logoCompanies Like Relay Therapeutics (NASDAQ:RLAY) Are In A Position To Invest In Growth
finance.yahoo.com - October 25 at 2:46 PM
markets.businessinsider.com logoStifel Nicolaus Reaffirms Their Buy Rating on Relay Therapeutics (RLAY)
markets.businessinsider.com - October 19 at 12:04 AM
Get Relay Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter.



RLAY Media Mentions By Week

RLAY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RLAY
News Sentiment

0.89

0.65

Average
Medical
News Sentiment

RLAY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RLAY Articles
This Week

5

2

RLAY Articles
Average Week

Get Relay Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:RLAY) was last updated on 3/3/2024 by MarketBeat.com Staff